Biologics for Stricturing Crohn's Diseases
Recruiting · NCT05645055 · Observational (researchers observe without assigning treatment) · Lead sponsor: Jinling Hospital, China
View the official record on ClinicalTrials.gov →Interventions studied
treat these patients with biologics
What this trial is about
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Who can take part
Age range
16 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- patients with stricturing Crohn's diseases
- no surgical indication
- patients with asymptomatic penetrating diseases
- written consent acquired
Exclusion criteria
- patients with surgical indication
- patients with symptomatic penetrating diseases
- contraindication of biologics
- anticipating other trial
Where it is running
1 location listed.
- Department of General Surgery, Jinling hosptal,Medical School of Nanjing University - Nanjing, Jiangsu, China